NEXTSTELLIS

Identification of Nextstellis

No description

Google image searchProduct monograph

Active ingredients

estetrol monohydrate, 15 MG

drospirenone, 3 MG

DIN: 02513218

Dosage form(s): TABLET

Route(s) of administration: ORAL

Description: 24 PINK ACTIVE TABLETS + 4 WHITE INERT TABLETS

Schedule: Prescription

Company: SEARCHLIGHT PHARMA INC

Date: 15-JUN-2021

ATC:

Reference brand drug: Nextstellis

Search on Google